BR9610679A - Antígenos de leishmania para uso na terapia e disgnose da leishmaniose - Google Patents

Antígenos de leishmania para uso na terapia e disgnose da leishmaniose

Info

Publication number: BR9610679A
Authority: BR; Brazil
Prior art keywords: leishmaniasis; dysgnosis; therapy; leishmania antigens; leishmania
Prior art date: 1995-09-22

Application number

BR9610679A

Other languages

English (en)

Other versions

BRPI9610679B1 (pt

Inventor

John R Webb

Yasir A W Skeiky

Steven G Reed

Davin C Dillon

Antonio Campos-Neto

Original Assignee

Corixa Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-22

Filing date

1996-09-20

Publication date

1999-03-30

1996-09-20 Application filed by Corixa Corp filed Critical Corixa Corp

1999-03-30 Publication of BR9610679A publication Critical patent/BR9610679A/pt

2017-05-16 Publication of BRPI9610679B1 publication Critical patent/BRPI9610679B1/pt

Links

208000004554 Leishmaniasis Diseases 0.000 title abstract 4
241000222722 Leishmania <genus> Species 0.000 title abstract 2
239000000427 antigen Substances 0.000 title abstract 2
102000036639 antigens Human genes 0.000 title abstract 2
108091007433 antigens Proteins 0.000 title abstract 2
238000002560 therapeutic procedure Methods 0.000 title abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

BRPI9610679A 1995-09-22 1996-09-20 vetor de expressão recombinante, composição farmacêutica e vacina BRPI9610679B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/533,669 US5834592A (en)	1995-09-22	1995-09-22	Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
PCT/US1996/015185 WO1997011180A1 (en)	1995-09-22	1996-09-20	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Publications (2)

Publication Number	Publication Date
BR9610679A true BR9610679A (pt)	1999-03-30
BRPI9610679B1 BRPI9610679B1 (pt)	2017-05-16

Family

ID=24126960

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI9610679A BRPI9610679B1 (pt)	1995-09-22	1996-09-20	vetor de expressão recombinante, composição farmacêutica e vacina

Country Status (9)

Country	Link
US (2)	US5834592A (pt)
EP (1)	EP0854924B1 (pt)
AT (1)	ATE243750T1 (pt)
AU (1)	AU7242796A (pt)
BR (1)	BRPI9610679B1 (pt)
DE (1)	DE69628844T2 (pt)
ES (1)	ES2205059T3 (pt)
PT (1)	PT854924E (pt)
WO (1)	WO1997011180A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6013268A (en) *	1994-04-22	2000-01-11	Corixa Corporation	Methods for enhancement of protective immune responses
US6638517B2 (en)	1995-09-22	2003-10-28	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US5834592A (en)	1995-09-22	1998-11-10	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6613337B1 (en)	1997-02-12	2003-09-02	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6365165B1 (en)	1995-09-22	2002-04-02	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6607731B1 (en)	1995-09-22	2003-08-19	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6375955B1 (en) *	1995-09-22	2002-04-23	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6500437B1 (en)	1995-09-22	2002-12-31	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ATE530651T1 (de) *	1997-02-12	2011-11-15	Corixa Corp	Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose
EP0981624A2 (en) *	1997-02-12	2000-03-01	Corixa Corporation	$i(LEISHMANIA) ANTIGENS FOR USE IN THE THERAPY AND DIAGNOSIS OF LEISHMANIASIS
GB9924351D0 (en) *	1999-10-14	1999-12-15	Brennan Frank	Immunomodulation methods and compositions
GB0008305D0 (en) *	2000-04-06	2000-05-24	Neutec Pharma Plc	Treatment of fungal infections
US6673351B1 (en)	2001-03-16	2004-01-06	Astralis, Llc	Compositions and methods for the treatment and clinical remission of psoriasis
US20040241168A1 (en) *	2001-03-16	2004-12-02	O'daly Jose A.	Compositions and methods for the treatment and clinical remission of psoriasis
ES2323131T3 (es) *	2003-12-23	2009-07-07	All India Institute Of Medical Sciences	Oligonucleotidos para la deteccion de leishmaniasis y metodos correspondientes.
EP1711520B1 (en) *	2003-12-26	2010-02-10	All India Institute of Medical Sciences	Polypeptides for the diagnosis and therapy of leishmaniasis
US7833534B2 (en)	2006-04-10	2010-11-16	Infectious Disease Research Institute	Compounds and methods for diagnosis and treatment of leishmaniasis
AR073452A1 (es)	2008-07-03	2010-11-10	Infectious Disease Res Inst	Proteinas de fusion que comprende dos o mas antigenos de leishmania y su uso en el diagnostico y tratamiento de leishmaniasis
EP2978447B1 (en)	2013-03-28	2019-05-08	Infectious Disease Research Institute	Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
WO2015171395A2 (en) *	2014-05-05	2015-11-12	Purdue Research Foundation	Degradation resistant peptide based biosensors
TR202006914A1 (tr) *	2020-05-04	2021-11-22	Univ Yeditepe	İmmunoprofi̇lakti̇k ve i̇mmunoterapöti̇k olarak ekstraselüler vezi̇külleri̇ni̇n lei̇shmani̇asi̇s hastaliği i̇çi̇n kullanimi
FR3115681B1 (fr)	2020-11-04	2024-12-20	Vaxinano	Vaccin therapeutique comprenant un antigene specifique d’une maladie n’atteignant pas le systeme nerveux central et des nanoparticules et son utilisation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4870006A (en) *	1986-07-24	1989-09-26	Codon	Antigenic material for a chagas' disease detection system
US5411865A (en) *	1993-01-15	1995-05-02	Iasys Corporation	Method of detecting anti-leishmania parasite antibodies
US5571515A (en)	1994-04-18	1996-11-05	The Wistar Institute Of Anatomy & Biology	Compositions and methods for use of IL-12 as an adjuvant
JP3350551B2 (ja) *	1994-04-22	2002-11-25	コリクサコーポレイション	保護的免疫応答及びｉｌ−１２産生の刺激及び促進のための化合物及び方法
US6013268A (en) *	1994-04-22	2000-01-11	Corixa Corporation	Methods for enhancement of protective immune responses
US5879687A (en) *	1994-04-22	1999-03-09	Corixa Corporation	Methods for enhancement of protective immune responses
US5876735A (en) *	1994-04-22	1999-03-02	Corixa Corporation	Methods for enhancement of protective immune responses
US5965142A (en) *	1995-08-04	1999-10-12	Corixa Corporation	Polypeptides and methods for the detection of L. tropica infection
US5834592A (en)	1995-09-22	1998-11-10	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6054135A (en) *	1996-11-14	2000-04-25	Corixa	Compounds and methods for the detection and prevention of T. cruzi infection
US5744593A (en) *	1996-02-15	1998-04-28	Heska Corporation	Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules

1995
- 1995-09-22 US US08/533,669 patent/US5834592A/en not_active Expired - Lifetime
1996
- 1996-09-20 DE DE69628844T patent/DE69628844T2/de not_active Expired - Lifetime
- 1996-09-20 BR BRPI9610679A patent/BRPI9610679B1/pt not_active IP Right Cessation
- 1996-09-20 EP EP96933854A patent/EP0854924B1/en not_active Expired - Lifetime
- 1996-09-20 AU AU72427/96A patent/AU7242796A/en not_active Abandoned
- 1996-09-20 WO PCT/US1996/015185 patent/WO1997011180A1/en not_active Ceased
- 1996-09-20 AT AT96933854T patent/ATE243750T1/de not_active IP Right Cessation
- 1996-09-20 ES ES96933854T patent/ES2205059T3/es not_active Expired - Lifetime
- 1996-09-20 PT PT96933854T patent/PT854924E/pt unknown
1997
- 1997-02-12 US US08/798,841 patent/US6709661B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0854924B1 (en)	2003-06-25
BRPI9610679B1 (pt)	2017-05-16
MX9802284A (es)	1998-08-30
US6709661B1 (en)	2004-03-23
ATE243750T1 (de)	2003-07-15
EP0854924A1 (en)	1998-07-29
AU7242796A (en)	1997-04-09
PT854924E (pt)	2003-11-28
DE69628844T2 (de)	2004-05-19
DE69628844D1 (de)	2003-07-31
WO1997011180A1 (en)	1997-03-27
ES2205059T3 (es)	2004-05-01
US5834592A (en)	1998-11-10

Legal Events

Date	Code	Title	Description
2003-05-27	FB36	Technical and formal requirements: requirement - article 36 of industrial property law
2003-06-17	HKFB	Grant procedure suspended (deleted)
2004-04-20	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2005-03-15	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2005-12-27	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: DE ACORDO COM ART. 37 DA LEI 9.279, DE 14/05/1996, EM COMBINACAO COM O DISPOSTO PELO INCISO (X) ART.10 E ARTS. 24 E25 DA MESMA LEI.
2006-04-04	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2012-03-27	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2017-05-16	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
2017-07-25	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
2017-10-31	B24D	Patent annual fee: restoration after fee payment
2019-07-16	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 23A ANUIDADE.
2019-11-05	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2532 DE 16-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BR9610679A (pt)	1999-03-30	Antígenos de leishmania para uso na terapia e disgnose da leishmaniose
FI922620A7 (fi)	1992-06-05	Peptidijohdannainen, menetelmä sen valmistamiseksi, sitä sisältävä far maseuttinen valmiste ja menetelmä glaukooman hoitamiseksi
PT1203817E (pt)	2006-08-31	Compostos e metodos para imunoterapia e le diagnostic de tuberculose
ES2176232T3 (es)	2002-12-01	Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
BR9106114A (pt)	1993-03-09	Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
YU28392A (sh)	1994-11-15	Vakcina koja sadrži glikoprotein d i 3deacilovani monofosforil lipid a
AU7814498A (en)	1998-12-30	Multivalent (in ovo) avian vaccine
MXPA02010173A (es)	2003-06-04	Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis.
NL300189I1 (nl)	2005-06-01	Acellulair vaccin.
WO1998035045A3 (en)	1998-10-29	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
DE10075036I2 (de)	2005-07-07	Impfstoff und Diagnostikum f}r den Schweine-Cholera-Virus.
WO2002098359A3 (en)	2003-04-03	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ES2057008T3 (es)	1994-10-16	Medicamento.
EP1422238A3 (en)	2004-12-15	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
DE69010523D1 (de)	1994-08-18	Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
CA2133108A1 (en)	1993-10-14	Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
IT8919574A0 (it)	1989-02-28	Procedimento ed impianto per la preparazione di prodotti farmaceutici in genere.
IT8919204A0 (it)	1989-01-26	Composizione per la prevenzione e la cura di parodontopatte.
GB9618119D0 (en)	1996-10-09	Adjuvants for use in vaccines